Reasons why patients with tuberculosis in South Korea stop anti-TB treatment: A cross-sectional study

H. W. Kim, J. Min, A. Y. Shin, H. K. Koo, S. Y. Lim, M. J. Park, Y. B. Park, J. Lee, S. S. Lee, J. S. Park, J. S. Kim

Research output: Contribution to journalArticlepeer-review

9 Citations (Scopus)

Abstract

BACKGROUND: As there had been no reduction in the TB burden in South Korea since 2000, a public-private mix (PPM) strategy was launched in 2011. The purpose of this study was to investigate the reasons for lost to follow-up (LTFU) among TB patients and their clinical characteristics. METHOD: A multicentre, cross-sectional study based on in-depth interviews with patients and their families by TB specialist nurses was conducted. Patients who were reported with a final outcome of LTFU in 2015-2017 at all PPM hospitals across the country were enrolled. Enrolled patients were classified into six subgroups by age and three major reasons for LTFU (adverse effects, refusal of treatment, marginalisation) and their clinical features were compared. RESULTS: Among 780 patients, those who were lost to follow-up due to adverse effects accounted for the largest proportion (n ¼ 387). LTFU in those aged,65 years who refused treatment (n ¼ 189) and those aged,65 years who were marginalised (n ¼ 108) were related to having smear-positive TB and a previous history of unfavourable outcomes. CONCLUSION: To reduce LTFU in South Korea, comprehensive strategies, including management of adverse effects, systematic counselling and education, should be implemented.

Original languageEnglish
Pages (from-to)1016-1023
Number of pages8
JournalInternational Journal of Tuberculosis and Lung Disease
Volume24
Issue number10
DOIs
Publication statusPublished - 1 Oct 2020

Bibliographical note

Publisher Copyright:
© 2020 The Union

Keywords

  • Medication adherence
  • Public-private sector partnerships
  • Republic of Korea
  • TB

Fingerprint

Dive into the research topics of 'Reasons why patients with tuberculosis in South Korea stop anti-TB treatment: A cross-sectional study'. Together they form a unique fingerprint.

Cite this